Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergoogle.co.uk
Google Alert - "golimumab biosimilar"
Get the latest updates from Google Alert - "golimumab biosimilar" directly as they happen.
Follow now < 10 followers
Latest posts
Last updated 1 day ago
China's Bio-Thera Gets US Nod for Golimumab Biosimilar - Yicai Global
2 days ago
(Yicai) May 19 -- Bio-Thera Solutions said that the Chinese biopharmaceutical company's...
Bio-Thera/Accord BioPharma Secure First FDA Approval of Golimumab Biosimilars
2 days ago
These are the first golimumab biosimilars to be approved in the US...
Bio-Thera Solutions' Golimumab Biosimilars Receive FDA Approval as First ... - StreetInsider
3 days ago
the United States of America for IMMGOLIS (formerly known as BAT2506), a...
FDA Approves Immgolis and Immgolis Intri as First Biosimilars to Golimumab Reference ...
3 days ago
FDA approval clears interchangeable golimumab biosimilar for rheumatoid arthritis and ulcerative colitis...
Bio-Thera Solutions' Golimumab Biosimilars Receive FDA Approval as First ... - PR Newswire
3 days ago
... (golimumab) biosimilar, for the treatment of adults patients with moderately to...
FDA approves first interchangeable biosimilars to Simponi and Simponi Aria (golimumab) to ...
6 days ago
... Golimumab biosimilar Gotenfia from STADA and Bio-Thera receives positive CHMP opinion...
FDA approves denosumab biosimilar Ponlimsi
27 days ago
EC approves golimumab biosimilar Gotenfia and ranibizumab biosimilar Ranluspec. X-ray2 MD001884. Biosimilars/News...
Canada's Jamp Deepens Immunology Biosimilars Push - Citeline News & Insights
about 1 month ago
Jamp Pharma has secured Health Canada approval for Upgolyv, a golimumab biosimilar...
JAMP Pharma Group Strengthens Its Immunology Biosimilars Portfolio with PrUpgolyv™, a ...
about 1 month ago
As a Canadian-owned company, we are proud to offer this authorized golimumab...
JAMP Pharma Group Strengthens Its Immunology Biosimilars Portfolio with PrUpgolyv™, a ...
about 1 month ago
JAMP Pharma Group Strengthens Its Immunology Biosimilars Portfolio with PrUpgolyv™, a Golimumab...
EMA recommends approval of three new biosimilars for diabetes and autoimmune conditions
about 1 month ago
EC approves golimumab biosimilar Gotenfia and ranibizumab biosimilar Ranluspec · EMA recommends...
Goodwin Advises Tubulis on Acquisition by Gilead for $3.15 Billion Upfront and Up to $1.85 ...
about 1 month ago
March 26, 2026. Bio-Thera and Intas Expand Golimumab Biosimilar Partnership to India...